Fresenius SE & Co. (OTCMKTS:FSNUY) Reaches New 52-Week Low – Here’s Why

Posted by Stacy Sanders on May 13th, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as $11.2271 and last traded at $11.27, with a volume of 48031 shares. The stock had previously closed at $11.71.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on FSNUY shares. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy”.

Get Our Latest Research Report on FSNUY

Fresenius SE & Co. Price Performance

The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47. The company has a 50 day moving average price of $12.87 and a 200 day moving average price of $14.09. The company has a market capitalization of $25.57 billion, a P/E ratio of 15.13 and a beta of 0.68.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%.The business had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. On average, equities analysts predict that Fresenius SE & Co. will post 1.05 EPS for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.